Clinical Trial Update: Clinical Study of Treating Type 2 Diabetic Nephropathy With Alfacalcidol and Irbesartan [Phase 4]

View source ↗

Summary

Phase 4 clinical study evaluating alfacalcidol in combination with irbesartan for type 2 diabetic nephropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus with Nephropathy
• Type 2 Diabetic Nephropathy

Drugs mentioned

• Alfacalcidol (alfacalcidol)
• Irbesartan (irbesartan)

Snippet

Sponsor: The Third Xiangya Hospital of Central South University | Conditions: Type 2 Diabetic Nephropathy | Phase 4 | Status: COMPLETED